Cipla Limited (CIPLA.NS)

1,347.30 -27.90 (-2.03%) At close: 03:30PM IST

Cipla Limited

Cipla House
Peninsula Business Park Ganpatrao Kadam Marg Lower Parel
Mumbai 400013
India
91 22 2482 6000
https://www.cipla.com

Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full-time employees: 32,323

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Umang Vohra B.E., M.B.A.	MD, Global CEO & Executive Director	174.9M	N/A	1971
Dr. Raju Sunil Mistry M.A., Ph.D.	President & Global Chief People Officer	N/A	N/A	1965
Mr. Pradeep Bhadauria	President & Chief Scientific Officer	N/A	N/A	N/A
Mr. Ashish Adukia	Global Chief Financial Officer	N/A	N/A	N/A
Mr. Dinesh Ramniranjan Jain	Senior VP & Head of Corporate Finance	N/A	N/A	N/A
Ms. Geena V. Malhotra	Global Chief Technology Officer	N/A	N/A	N/A
Mr. Naveen Bansal	Head of Investor Relations	N/A	N/A	N/A
Mr. Rajendra Kumar Chopra	Compliance Officer & Company Secretary	15.3M	N/A	N/A
Ms. Heena Kanal	Senior Vice-President of Corporate Communications	N/A	N/A	N/A
Mr. Anurag Mishra	Head of Cipla Foundation	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. In addition, the company provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Further, it offers Easylax and Easylax L, a liquid paraffin for constipation. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Corporate governance

Cipla Limited’s ISS governance QualityScore as of 1 April 2024 is 4. The pillar scores are Audit: 4; Board: 3; Shareholder rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.